• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Intraperitoneal perfusion of gemtuzumab-ozogamicin combined with allogeneic hematopoietic stem cell transplantation in intestinal solitary myeloid sarcoma: a case report and literature review].

作者信息

Fu W J, Gao L, Lu G H, Yang J M

机构信息

Department of Hematology, Institute of Hematology, Changhai Hospital Affiliated to Navy Military Medical University, Shanghai 200433, China.

出版信息

Zhonghua Xue Ye Xue Za Zhi. 2020 Aug 14;41(8):683-685. doi: 10.3760/cma.j.issn.0253-2727.2020.08.013.

DOI:10.3760/cma.j.issn.0253-2727.2020.08.013
PMID:32942825
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7525164/
Abstract
摘要

相似文献

1
[Intraperitoneal perfusion of gemtuzumab-ozogamicin combined with allogeneic hematopoietic stem cell transplantation in intestinal solitary myeloid sarcoma: a case report and literature review].[吉妥珠单抗-奥唑米星腹腔灌注联合异基因造血干细胞移植治疗肠道孤立性髓系肉瘤：1例报告并文献复习]
Zhonghua Xue Ye Xue Za Zhi. 2020 Aug 14;41(8):683-685. doi: 10.3760/cma.j.issn.0253-2727.2020.08.013.
2
Treatment of myeloid sarcoma without bone marrow involvement with gemtuzumab ozogamicin-containing regimen.
Leuk Res. 2021 Jul;106:106583. doi: 10.1016/j.leukres.2021.106583. Epub 2021 Apr 22.
3
Population Pharmacokinetic Modeling of Gemtuzumab Ozogamicin in Adult Patients with Acute Myeloid Leukemia.成人急性髓系白血病患者吉妥珠单抗奥佐米星的群体药代动力学模型。
Clin Pharmacokinet. 2019 Mar;58(3):335-347. doi: 10.1007/s40262-018-0699-5.
4
Gemtuzumab ozogamicin in children with relapsed or refractory acute myeloid leukemia: a report by Berlin-Frankfurt-Münster study group.吉妥珠单抗奥佐米星治疗复发或难治性急性髓系白血病的儿童患者：来自柏林-法兰克福-明斯特研究组的报告。
Haematologica. 2019 Jan;104(1):120-127. doi: 10.3324/haematol.2018.191841. Epub 2018 Aug 9.
5
Preliminary results of the safety of immunotherapy with gemtuzumab ozogamicin following reduced intensity allogeneic stem cell transplant in children with CD33+ acute myeloid leukemia.吉妥单抗奥佐米星免疫疗法在CD33+急性髓系白血病儿童患者中进行减低强度异基因干细胞移植后的安全性初步结果。
Clin Cancer Res. 2005 Oct 1;11(19 Pt 2):7164s-7170s. doi: 10.1158/1078-0432.CCR-1004-0018.
6
Association of fludarabin, cytarabine, and fractioned gemtuzumab followed by hematopoietic stem cell transplantation for first-line refractory acute myeloid leukemia in children: A single-center experience.氟达拉滨、阿糖胞苷和分次吉妥珠单抗联合造血干细胞移植治疗儿童一线难治性急性髓系白血病：单中心经验。
Pediatr Blood Cancer. 2020 Jun;67(6):e28305. doi: 10.1002/pbc.28305. Epub 2020 Apr 19.
7
Allogeneic hematopoietic stem cell transplantation for isolated and leukemic myeloid sarcoma in adults: a report from the Acute Leukemia Working Party of the European group for Blood and Marrow Transplantation.成人孤立性和白血病性髓系肉瘤的异基因造血干细胞移植：欧洲血液与骨髓移植组急性白血病工作组的报告
Haematologica. 2011 Sep;96(9):1391-4. doi: 10.3324/haematol.2011.041418. Epub 2011 Jun 17.
8
Intermediate dose cytarabine in treatment myeloid sarcoma of the bilateral breast after allogeneic stem cell transplantation: A case report and literature review.异基因干细胞移植后中剂量阿糖胞苷治疗双侧乳腺髓系肉瘤：1例报告及文献复习
J Cancer Res Ther. 2018 Apr-Jun;14(3):703-705. doi: 10.4103/0973-1482.174174.
9
Gemtuzumab ozogamicin therapy for isolated extramedullary AML relapse after allogeneic hematopoietic stem-cell transplantation.异基因造血干细胞移植后孤立性髓外 AML 复发的吉妥珠单抗奥佐米星治疗。
Tohoku J Exp Med. 2010 Feb;220(2):121-6. doi: 10.1620/tjem.220.121.
10
Gemtuzumab ozogamicin for acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trial.吉妥珠单抗奥佐米星治疗急性髓系白血病：来自开放标签、III 期 ALFA-0701 试验的最终疗效和安全性更新。
Haematologica. 2019 Jan;104(1):113-119. doi: 10.3324/haematol.2018.188888. Epub 2018 Aug 3.

本文引用的文献

1
Clinical and imaging features of myeloid sarcoma: a German multicenter study.髓样肉瘤的临床和影像学特征：一项德国多中心研究。
BMC Cancer. 2019 Nov 27;19(1):1150. doi: 10.1186/s12885-019-6357-y.
2
Pediatric myeloid sarcoma: a single institution clinicopathologic and molecular analysis.儿童髓系肉瘤：单机构临床病理与分子分析
Pediatr Hematol Oncol. 2020 Feb;37(1):76-89. doi: 10.1080/08880018.2019.1683107. Epub 2019 Nov 4.
3
Complete response of myeloid/lymphoid neoplasms with PDGFRA rearrangement presenting as leukemia/myeloid sarcoma to imatinib monotherapy.表现为白血病/髓系肉瘤的伴有血小板衍生生长因子受体α（PDGFRA）重排的髓系/淋系肿瘤对伊马替尼单药治疗的完全缓解
Chin Med J (Engl). 2019 Oct 20;132(20):2498-2500. doi: 10.1097/CM9.0000000000000437.
4
Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology.急性髓细胞白血病，第 3.2019 版，NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2019 Jun 1;17(6):721-749. doi: 10.6004/jnccn.2019.0028.
5
Clinical and Radiographic Response of Extramedullary Leukemia in Patients Treated With Gemtuzumab Ozogamicin.接受吉妥珠单抗奥唑米星治疗的患者髓外白血病的临床和影像学反应
J Pediatr Hematol Oncol. 2019 Apr;41(3):e174-e176. doi: 10.1097/MPH.0000000000001201.
6
Clinical characteristics, molecular profile and outcomes of myeloid sarcoma: a single institution experience over 13 years.髓系肉瘤的临床特征、分子特征及预后：一家机构13年的经验
Hematology. 2018 Jan;23(1):17-24. doi: 10.1080/10245332.2017.1333275. Epub 2017 Jun 2.
7
Myeloid Sarcoma: Presentation, Diagnosis, and Treatment.髓系肉瘤：临床表现、诊断与治疗
Clin Lymphoma Myeloma Leuk. 2017 May;17(5):263-267. doi: 10.1016/j.clml.2017.02.027. Epub 2017 Mar 7.
8
Clinical outcome of myeloid sarcoma in adult patients and effect of allogeneic stem cell transplantation. Results from a multicenter survey.成年患者髓系肉瘤的临床结局及异基因干细胞移植的效果。一项多中心调查结果
Leuk Res. 2017 Feb;53:74-81. doi: 10.1016/j.leukres.2016.12.003. Epub 2016 Dec 20.
9
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.2016 年版世界卫生组织髓系肿瘤和急性白血病分类。
Blood. 2016 May 19;127(20):2391-405. doi: 10.1182/blood-2016-03-643544. Epub 2016 Apr 11.
10
Extramedullary Manifestations of Myeloid Neoplasms.髓系肿瘤的髓外表现
Am J Clin Pathol. 2015 Aug;144(2):219-39. doi: 10.1309/AJCPO58YWIBUBESX.